Clinical Study
Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV
Table 3
Multiple regression analysis for factors associated with cancer mortality.
| |
Standardized coefficient |
SE | t value | value | 95% confidence interval | Lower | Upper |
| Intercept | −0.594 | 0.194 | −3.059 | 0.003 | −0.978 | −0.211 | Age | 0.104 | 0.003 | 1.405 | 0.162 | −0.002 | 0.009 | Followup period | −0.023 | 0.004 | −0.322 | 0.748 | −0.009 | 0.0067 | Postoperative one month 131I uptake | 0.055 | 0.003 | 0.784 | 0.434 | −0.003 | 0.008 | Gender: female/male | 0.344 | 0.053 | 4.829 | 0.000 | 0.152 | 0.361 | Postoperative one month Tg | −0.051 | 0.001 | −0.688 | 0.434 | 0.000 | 0.001 | TNM stage | 0.140 | 0.027 | 1.98 | 0.049 | 0.002 | 0.107 |
|
|
Dependent variable: cancer mortality (yes/no).
|